scholarly journals Recurrent urinary infections in general practice

1970 ◽  
Vol 23 (3) ◽  
pp. 259-261 ◽  
Author(s):  
R. N. Gruneberg
1987 ◽  
Vol 25 (18) ◽  
pp. 69-72

Ciprofloxacin (Ciproxin - Bayer) is the first of the new fluoroquinolone drugs to be introduced in Britain. Others, pefloxacin, norfloxacin, and ofloxacin are undergoing clinical trials. All are 60 times more active than nalidixic acid, the best known early quinolone, and reach bactericidal concentrations at many sites against a much wider range of organisms. Ciprofloxacin can be given by mouth or intravenously. It is strongly promoted for use in respiratory and urinary infections in general practice and in hospital. Several sponsored publications report on it.1–4


The Lancet ◽  
1976 ◽  
Vol 307 (7970) ◽  
pp. 1184-1185 ◽  
Author(s):  
John Crump ◽  
Linda Pead ◽  
Rosalind Maskell

The Lancet ◽  
1965 ◽  
Vol 285 (7386) ◽  
pp. 653
Author(s):  
J STANSFELD

1973 ◽  
Vol 11 (24) ◽  
pp. 93-94

We recently reviewed the use of long-term low-dose chemotherapy to prevent recurrent urinary infections1 and briefly mentioned instructions which could be given to patients to supplement the drug treatment. The effectiveness of such measures is not readily tested by conventional trials, but many clinicians consider that they can help patients with bacterial cystitis and are also worth trying in those women with frequent symptoms of cystitis but without bacteriuria. Only about half the women presenting with urinary symptoms in general practice have infected urine. Recurrent urinary symptoms may be due to the urethral syndrome, gynaecological disorders or even psychiatric disturbances.


1967 ◽  
Vol 5 (14) ◽  
pp. 55-56

PENICILLIN-SULPHONAMIDE MIXTURES - Numerous preparations containing a penicillin together with one or more sulphonamides have been available since the 1950s, but specialists concerned with the treatment of infections have never considered these mixtures important. In recent years they have been little advertised, and seemed to be heading for a quiet oblivion when fresh claims appeared for Penitriad (M & B) some months ago, advocating it ‘for common infections in general practice’, including boils, urinary infections, chronic bronchitis and prophylactic use in surgery and obstetrics. In our view the use of any penicillin-sulphonamide mixture for such purposes is inappropriate.


Chemotherapy ◽  
1976 ◽  
pp. 381-384
Author(s):  
G. A. Takken ◽  
Wijk-aan-Zee Holland ◽  
Valerie M. Moss ◽  
W. Brumfitt

Sign in / Sign up

Export Citation Format

Share Document